Drug profile · INN
mephentermine sulfate
WYAMINE SULFATE
mephentermine sulfate (WYAMINE SULFATE) is a adrenergic receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — mephentermine sulfate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
mephentermine sulfate (WYAMINE SULFATE) is a adrenergic receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor agonist
Primary target: Adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is mephentermine sulfate?
mephentermine sulfate (WYAMINE SULFATE) is a adrenergic receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for mephentermine sulfate?
WYAMINE SULFATE is a marketed brand name for mephentermine sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mephentermine sulfate?
mephentermine sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.